성장을 멈추지 마세요

체험은 만족하셨나요?

현재 45,775명이 마이메르시로 공부 중이에요

지식 자료를 소장하고 멋진 의료인으로 성장하세요

학습 자료 둘러보기 →
Anaphylaxis | 마이메르시 MyMerci
제안하기

뭔가 하고 싶은 말이 있는거야?

0 / 2000
컨텐츠 수정하기

컨텐츠 내용을 수정할 수 있습니다

수정하기
닫기

Anaphylaxis

NCLEX Review Guide: Anaphylaxis

Pathophysiology of Anaphylaxis

Definition and Mechanism

  • Anaphylaxis is a severe, potentially life-threatening systemic hypersensitivity reaction characterized by rapid onset and involvement of multiple body systems. It occurs when a sensitized individual is re-exposed to an allergen, triggering massive mast cell and basophil degranulation with release of inflammatory mediators.
  • The primary mediator in anaphylaxis is histamine, which causes vasodilation, increased vascular permeability, bronchoconstriction, and increased mucus production. Other mediators include leukotrienes, prostaglandins, and platelet-activating factor.

Key Points

  • Anaphylaxis is a Type I (immediate) hypersensitivity reaction mediated primarily by IgE antibodies.
  • The reaction can progress rapidly from mild symptoms to life-threatening respiratory and cardiovascular collapse within minutes.

Common Triggers

  • Food allergens are leading triggers, particularly peanuts, tree nuts, shellfish, fish, milk, eggs, wheat, and soy. Food allergies are more common in children but can affect individuals of any age.
  • Medication triggers include antibiotics (especially penicillins, cephalosporins, sulfonamides), NSAIDs, aspirin, chemotherapeutic agents, biologics, and contrast media used in diagnostic procedures.
  • Other common triggers include insect stings (bees, wasps, hornets, fire ants), latex (especially in healthcare workers), and exercise (either alone or food-dependent).

Key Points

  • Always obtain a thorough allergy history from patients before administering medications or performing procedures.
  • Cross-reactivity can occur between similar allergens (e.g., different types of shellfish or different penicillin-class antibiotics).

Clinical Manifestations

Systemic Signs and Symptoms

  • Cutaneous manifestations (present in 80-90% of cases) include flushing, pruritus, urticaria (hives), and angioedema. These are often the earliest signs but may be absent in severe, rapid-onset reactions.
  • Respiratory symptoms include rhinorrhea, nasal congestion, sneezing, hoarseness, stridor, dyspnea, wheezing, and respiratory arrest. Upper airway edema can lead to life-threatening airway obstruction.
  • Cardiovascular manifestations include tachycardia, hypotension, dizziness, syncope, and shock. Cardiovascular collapse results from vasodilation and increased vascular permeability leading to reduced preload.
  • Gastrointestinal symptoms include nausea, vomiting, abdominal cramping, and diarrhea, which are especially common with food allergens.

Key Points

  • Anaphylaxis typically affects two or more body systems simultaneously.
  • The absence of skin findings does not rule out anaphylaxis.

Clinical Scenario: Identifying Anaphylaxis

A 45-year-old patient receives IV ceftriaxone for pneumonia. Within 5 minutes, the patient reports feeling "strange" and "itchy all over." Assessment reveals urticaria on the trunk, respiratory rate of 28 with audible wheezing, HR 120, BP 90/50 (baseline 130/80). The patient appears anxious and states, "I can't catch my breath." These multi-system findings (cutaneous, respiratory, cardiovascular) occurring rapidly after antibiotic administration are classic for anaphylaxis requiring immediate intervention.

Nursing Assessment and Diagnosis

Assessment Priorities

  • Perform a rapid assessment of airway, breathing, and circulation (ABCs). Assess for stridor, wheezing, respiratory distress, hypotension, and altered mental status, which indicate severe anaphylaxis requiring immediate intervention.
  • Obtain vital signs, focusing on respiratory rate, oxygen saturation, heart rate, and blood pressure. Serial measurements are essential to track progression and response to treatment.
  • Perform a focused assessment of skin for urticaria, angioedema (especially of lips, tongue, uvula), and flushing. Document the extent and progression of these findings.

Key Points

  • The speed of symptom onset often correlates with reaction severity—more rapid onset typically indicates a more severe reaction.
  • Biphasic reactions (recurrence of symptoms after initial resolution) can occur in up to 20% of cases, typically within 8-12 hours.

Nursing Diagnoses

  • Ineffective Breathing Pattern related to bronchoconstriction and laryngeal edema as evidenced by dyspnea, wheezing, and decreased oxygen saturation.
  • Decreased Cardiac Output related to vasodilation and increased vascular permeability as evidenced by hypotension, tachycardia, and altered mental status.
  • Anxiety related to difficulty breathing and sense of impending doom as evidenced by restlessness, verbalized fear, and increased sympathetic stimulation.
  • Risk for Impaired Gas Exchange related to altered oxygen supply resulting from bronchoconstriction and airway edema.

Key Points

  • Prioritize nursing diagnoses related to airway and circulation as these represent the most immediate life threats.
  • Recognize that patient anxiety is a physiologic response to hypoxemia and should be addressed through treatment of the underlying anaphylaxis.

Management and Treatment

Emergency Interventions

  1. Administer epinephrine 0.3-0.5 mg (1:1000 solution) intramuscularly in the anterolateral thigh. This is the first-line treatment for anaphylaxis and should not be delayed. May repeat every 5-15 minutes if symptoms persist.
  2. Ensure patent airway and administer high-flow oxygen. Position the patient appropriately (supine with legs elevated for hypotension; semi-Fowler's if respiratory distress predominates).
  3. Establish IV access with large-bore catheters (16-18 gauge) and initiate fluid resuscitation with crystalloids (normal saline or Ringer's lactate) at 1-2 L for adults.
  4. Continuously monitor vital signs, oxygen saturation, cardiac rhythm, and level of consciousness.
  5. Administer adjunctive medications as ordered: H₁ antihistamines (diphenhydramine), H₂ blockers (famotidine), corticosteroids (methylprednisolone), and nebulized albuterol for bronchospasm.

Key Points

  • Never delay epinephrine administration to administer antihistamines or steroids—epinephrine is the only medication shown to reverse anaphylaxis and prevent fatality.
  • The intramuscular route is preferred for epinephrine administration in most settings; intravenous epinephrine should be reserved for profound shock and administered only in highly monitored settings.

Comparison: First-Line vs. Adjunctive Treatments for Anaphylaxis

First-Line Treatment Adjunctive Treatments
  • Epinephrine (IM)
  • Acts within minutes
  • Addresses all pathophysiologic effects
  • Life-saving
  • Should NEVER be delayed
  • Antihistamines (H₁ and H₂ blockers)
  • Corticosteroids
  • Bronchodilators
  • Slower onset of action
  • Address specific symptoms
  • Do not prevent progression of reaction

CRITICAL NURSING ALERT

Patients on beta-blockers may have diminished response to epinephrine and may require higher doses or alternative agents such as glucagon. Always inform the provider if a patient experiencing anaphylaxis is taking beta-blockers.

Long-Term Management

  • Patients who have experienced anaphylaxis should be observed for at least 4-8 hours after symptom resolution due to the risk of biphasic reactions. Those with severe reactions may require overnight observation.
  • Prior to discharge, patients should receive education on allergen avoidance, recognition of early symptoms, and proper use of an epinephrine auto-injector. Ensure the patient has a prescription for at least two epinephrine auto-injectors.
  • Referral to an allergist/immunologist is recommended for follow-up testing, consideration of immunotherapy if appropriate, and development of an emergency action plan.

Key Points

  • Patients should be instructed to carry epinephrine auto-injectors at all times and to use them at the first sign of anaphylaxis, then seek immediate medical attention.
  • Medical alert jewelry identifying the patient's allergies is strongly recommended.

Commonly Confused Points

Anaphylaxis vs. Anaphylactoid Reactions

Anaphylaxis (IgE-mediated) Anaphylactoid Reactions (Non-IgE-mediated)
  • Requires prior sensitization
  • Mediated by IgE antibodies
  • Involves mast cell and basophil degranulation
  • Common triggers: foods, medications, insect venom
  • Can occur with minute amounts of allergen
  • No prior sensitization required
  • Not mediated by IgE antibodies
  • Direct mast cell activation
  • Common triggers: contrast media, opioids, NSAIDs, exercise
  • Often dose-dependent

Key Points

  • Despite different mechanisms, anaphylaxis and anaphylactoid reactions present with identical clinical manifestations and are treated the same way.
  • For NCLEX purposes, focus on recognizing the clinical presentation and emergency management rather than distinguishing between mechanisms.

Anaphylaxis vs. Other Acute Conditions

Condition Key Differentiating Features
Anaphylaxis Multi-system involvement, rapid onset, often with urticaria/angioedema, history of allergen exposure
Vasovagal Syncope Bradycardia (not tachycardia), pallor (not flushing), no urticaria or respiratory symptoms, often preceded by specific trigger (pain, fear)
Acute Asthma Exacerbation Primarily respiratory symptoms, no urticaria/angioedema, typically no hypotension, often slower onset
Panic Attack No urticaria/angioedema, no objective respiratory compromise, normal blood pressure, no response to epinephrine

Key Points

  • When in doubt about anaphylaxis vs. another condition, administer epinephrine—the risk of untreated anaphylaxis outweighs the risk of unnecessary epinephrine.
  • The presence of skin symptoms plus one other system involvement (respiratory, cardiovascular, gastrointestinal) strongly suggests anaphylaxis.

Epinephrine Routes and Dosing

Route Concentration Typical Dose Key Considerations
Intramuscular (IM) 1:1000 (1 mg/mL) 0.3-0.5 mg for adults
0.01 mg/kg for children (max 0.3 mg)		 Preferred route, anterolateral thigh, may repeat q5-15min
Intravenous (IV) 1:10,000 (0.1 mg/mL) 0.1 mg over 5 minutes Only for profound shock, requires continuous monitoring
Auto-injector Pre-measured Adult: 0.3 mg
Junior: 0.15 mg		 Designed for self-administration, delivers IM injection

DOSING ALERT

A common error is confusing epinephrine concentrations. For anaphylaxis, IM epinephrine is 1:1000 (1 mg/mL), while IV epinephrine is 1:10,000 (0.1 mg/mL). Using the wrong concentration can result in a 10-fold dosing error.

Study Tips and Memory Aids

Remember the "3 A's" of Anaphylaxis Assessment

  • Airway: Stridor, hoarseness, throat tightness
  • Appearance: Urticaria, angioedema, flushing
  • Affect: Anxiety, sense of doom, altered consciousness

ABCDE of Anaphylaxis Management

  • Adrenaline (Epinephrine) - First-line treatment
  • Breathing support - Oxygen, positioning, airway management
  • Circulation support - IV fluids, vasopressors if needed
  • Drugs (adjunctive) - Antihistamines, steroids, bronchodilators
  • Evaluation - Continuous monitoring, biphasic reaction watch

NCLEX Test-Taking Strategies

  • When presented with a scenario describing possible anaphylaxis, look for multi-system involvement (especially respiratory symptoms plus skin findings) and a temporal relationship to a potential trigger.
  • For questions about management priorities, remember that epinephrine administration is always the first intervention for anaphylaxis, followed by airway management and IV access.
  • When answering questions about patient education, prioritize allergen avoidance and proper use of epinephrine auto-injectors as the most important teaching points.

Key Points

  • For priority-setting questions, remember the ABCs (Airway, Breathing, Circulation) and that epinephrine administration is part of addressing all three simultaneously.
  • Be prepared to recognize anaphylaxis in atypical presentations, such as reactions without skin findings or in patients with confounding factors (e.g., beta-blocker use).

Common Pitfalls

  • Waiting for "classic" symptoms to appear before administering epinephrine. Anaphylaxis can present atypically, and early intervention is crucial.
  • Administering antihistamines or steroids instead of epinephrine as first-line treatment. These medications do not reverse the life-threatening aspects of anaphylaxis.
  • Discharging patients too early after symptom resolution. Biphasic reactions can occur hours after the initial reaction appears to resolve.
  • Failing to prescribe or teach proper use of epinephrine auto-injectors before discharge. This is essential for all patients who have experienced anaphylaxis.

Quick Knowledge Check

  1. What is the first-line medication for anaphylaxis? Epinephrine
  2. What is the preferred route of administration for epinephrine in anaphylaxis? Intramuscular (IM) in the anterolateral thigh
  3. How long should patients be observed after resolution of anaphylaxis symptoms? At least 4-8 hours
  4. Name three systems commonly affected by anaphylaxis: Cutaneous, respiratory, cardiovascular, gastrointestinal

Self-Assessment Checklist

  • I can identify the pathophysiology of anaphylaxis
  • I can recognize the clinical manifestations of anaphylaxis
  • I understand the emergency management of anaphylaxis
  • I can differentiate anaphylaxis from other acute conditions
  • I know the proper dosing and administration of epinephrine
  • I understand the importance of patient education and follow-up

Remember: Anaphylaxis is a true medical emergency where your quick assessment and decisive action can save a life. Trust your clinical judgment—when in doubt about anaphylaxis, administer epinephrine. You've got this!

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.